Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

BNTX
BioNTech SE
stock NASDAQ ADR

At Close
May 16, 2025 3:59:30 PM EDT
92.77USD+0.466%(+0.43)733,600
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 16, 2025 9:28:30 AM EDT
93.00USD+0.715%(+0.66)3,069
After-hours
May 16, 2025 4:00:30 PM EDT
92.77USD0.000%(0.00)1,048
OverviewOption ChainMax PainOptionsPrice & VolumeDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
10:22AM EST  A Look Into Healthcare Sector Value Stocks   Benzinga
Jan 27, 2022
03:16PM EST  Australia's TGA Says Pfizer's COVID-19 Vaccine Provisionally Approved For Use As A Booster In Individuals Aged 16-17 Years Old; Continues To Monitor Ongoing Trials Associated With Booster Doses For Younger Children   Benzinga
Jan 26, 2022
06:13AM EST  Bloomberg Reported BioNTech to Boost Staff by 50% at Biggest German Vaccine Factory   Benzinga
Jan 25, 2022
04:06PM EST  What Are Whales Doing With BioNTech   Benzinga
11:15AM EST  BioNTech Option Alert: Apr 14 $220 Calls Sweep (31) near the Ask: 98 @ $7.4 vs 43 OI; Ref=$155.05   Benzinga
10:07AM EST  Shares of vaccine manufacturer BioNTech SE (BNTX) are rising 5 percent on Tuesday's trading after the company and its partner Pfizer Inc. (PFE) announced the initiation of a clinical trial to evaluate an Omicron-based vaccine candidate in adults aged between 15 and 55 years.   RTTNews
07:46AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data   Benzinga
07:23AM EST  Pfizer Inc. (PFE) and BioNTech SE (BNTX) on Tuesday announced the initiation of a clinical trial to evaluate an Omicron-based vaccine candidate in adults 15 to 55 year of age.   RTTNews
06:51AM EST  Pfizer And BioNTech Initiate Study To Evaluate Omicron-Based COVID-19 Vaccine In Adults 18 To 55 Years Of Age   RTTNews
06:46AM EST  Pfizer And BioNTech Initiate Study To Evaluate Omicron-Based COVID-19 Vaccine In Adults 18-55 Years Of Age   Benzinga
06:45AM EST  -- First participants enrolled in clinical trial received Omicron-based vaccine candidate as a two-dose primary series and as a booster dose   GlobeNewswire Inc
Jan 24, 2022
12:44PM EST  Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows   Benzinga
06:59AM EST  Pfizer and BioNTech Publish Data From Two Lab Studies on Covid-19 Vaccine-induced Antibodies Ability to Neutralize SARS-COV-2 Omicron Variant; Both Data Sets Confirm Previously Announced Initial Study Results Demonstrating That Serum Antibodies Induced by BNT162B2 Neutralize the SARS-COV-2 Omicron Variant After Immunization With Three Doses   Benzinga
Jan 21, 2022
08:41AM EST  Lower COVID-19 Vaccine Sales Estimated Amid Less Severe Omicron Variant: Bloomberg   Benzinga
08:21AM EST  WHO Vaccine Advisory Group's Head Says Children Aged 5-11 Yrs A Low-Priority Use Group For Pfizer Vaccine, Except Those With Comorbidities   Benzinga
05:11AM EST  Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field   Benzinga
Jan 20, 2022
11:34AM EST  Sputnik V Associated With Higher Antibody Levels Against Omicron Than Pfizer, Study Shows: Reuters   Benzinga
Jan 19, 2022
04:07PM EST  Watching Vaccine And COVID-19 Testing Names As Biden In Speech Highlights Vaccination Progress, Encourages Boosters; Highlights Free Home Test Kits And Recent Purchase Of Pfizer Antiviral Pills   Benzinga
Jan 18, 2022
01:03PM EST  BZ NOTE: Report On Pfizer/BioNTech Vaccine Fourth Shot Study Results Via Israeli Lab Was Reported Monday Via Reuters   Benzinga
01:02PM EST  This Is What Whales Are Betting On BioNTech   Benzinga
01:01PM EST  Pfizer Shares Quiet Amid FT Report 'Fourth Pfizer jab ineffective in blocking Omicron, Israeli study shows'   Benzinga
11:39AM EST  WHO Chief Scientist Soumya Swaminathan Says There Is No Evidence Right Now That Healthy Children, Healthy Adolescents Need COVID-19 Boosters   Benzinga
10:13AM EST  EU Regulator Says No Evidence Seen Yet To Recommend 4th Dose Of COVID-19 Vaccines   Benzinga
10:04AM EST  Where BioNTech Stands With Analysts   Benzinga
09:07AM EST  Morgan Stanley Maintains Equal-Weight on BioNTech, Lowers Price Target to $284   Benzinga
02:03AM EST  4 Shots Of Pfizer COVID-19 Vaccine Not Enough To Prevent Omicron Infection, Say Israeli Researchers   Benzinga
Jan 17, 2022
10:54AM EST  Preliminary Study at Israeli Hospital Shows Fourth Shot of Pfizer/Biontech or Moderna Vaccine Leads to Higher Level of Antibodies Than After Third Shot, But Fourth Shot Is Still Not Effective Enough to Prevent Omicron Infection   Benzinga
10:50AM EST  Pfizer CEO Albert Bourla Said Monday Coronavirus will be Circulating for Many Years to Come, But Said Thinks Current Wave of Infections will be Final One that Requires Restrictions   Benzinga
Jan 14, 2022
01:25PM EST  Federal Health Officials Say Omicron-Targeted Shots May Not Be Necessary: WSJ   Benzinga
Jan 13, 2022
02:30PM EST  Supreme Court Blocks President Biden's Workplace Vaccine-Or-Test Mandate For Larger Employers; Grants Administration Request To Enforce Vaccine Mandate For Healthcare Workers Nationwide   Benzinga
12:24PM EST  Is The Launch Of A New Fund A Sell Signal For An Asset? Examples From Health Care, Commodities, And Now Bitcoin.   Benzinga
Jan 12, 2022
01:02PM EST  WHO's Technical Body Says Updated COVID-19 Vaccines Needed To Combat Omicron: Reuters   Benzinga
08:30AM EST  The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award   Benzinga
07:15AM EST  Pfizer Announces Positive Top-line Results From Phase 3 Study Of PREVNAR 20   RTTNews
Jan 11, 2022
02:44PM EST  Shares of vaccine makers are trading lower. The move is possibly due to a rotation into tech stocks, which gained amid a drop in yields.   Benzinga
10:25AM EST  EU Drug Regulator Says Should Be Careful In Not Overloading Immune System With Repeated COVID-19 Immunization   Benzinga
10:21AM EST  Shares of German biotechnology company BioNTech SE (BNTX) are down 4 percent on Tuesday's trading despite the company announcing that it would likely generate up to 17 billion euros or $19 billion in 2022 revenue from the COVID-19 vaccine it co-developed with partner Pfizer Inc. (PFE).   RTTNews
10:12AM EST  EU Drug Regulator Evaluating Application To Extend Use Of Pfizer-BioNTech Shot As Booster For 16-17 Year Olds, Expect Cos To Apply For Boosters In 12-15 Group As Well   Benzinga
07:12AM EST  BioNTech And InstaDeep Developed And Successfully Tested Early Warning System To Detect Potential High-Risk SARS-CoV-2 Variants   Benzinga
07:07AM EST  BioNTech, InstaDeep Developed Early Warning System To Detect Potential High-Risk SARS-CoV-2 Variants   RTTNews
07:00AM EST  BioNTech and InstaDeep Developed and Successfully Tested Early   GlobeNewswire Inc
Jan 10, 2022
09:13AM EST  BioNTech SE (BNTX) and privately-held immuno-oncology company Crescendo Biologics Ltd. announced Monday that they have entered a multi-target discovery collaboration to develop novel immunotherapies for the treatment of patients with cancer and other diseases. The initial term of the discovery collaboration is three years.   RTTNews
08:48AM EST  BioNTech And Crescendo Biologics To Develop Multi-specific Precision Immunotherapies   RTTNews
08:22AM EST  Pfizer CEO Says Working On A New Verse Of Vaccines Effective Against Omicron As Well As Other Variants   Benzinga
08:21AM EST  Pfizer CEO Says Don't Know If There Is A Need For A 4th Booster   Benzinga
08:07AM EST  BioNTech, Crescendo Biologics Announce Global Collaboration To Develop Multi-specific Precision Immunotherapies   Benzinga
08:00AM EST  BioNTech and Crescendo Biologics Announce Global Collaboration to   GlobeNewswire Inc
07:41AM EST  The Week Ahead In Biotech (Jan 10-15): JPMorgan Healthcare Conference Front And Center, Preannouncements Keep Coming   Benzinga
Jan 6, 2022
01:54PM EST  White House Says Vaccine Mandates Related To Schools Are Always Up To School Districts   Benzinga
Jan 5, 2022
05:10PM EST  CDC Advisers Vote In Favor Of Recommending Pfizer, BioNTech COVID-19 Vaccine Booster Dose For Ages 12-17 Years Old   Benzinga
08:20AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets   Benzinga
07:44AM EST  After Successful COVID-19 Vaccine, Pfizer, BioNTech Come Together For mRNA-Based Shingles Vaccine   Benzinga
07:13AM EST  Pfizer, BioNTech Join To Develop MRNA-based Vaccine   RTTNews
06:51AM EST  Pfizer, BioNTech Sign New Global Collaboration Deal To Develop First MRNA-based Shingles Vaccine   RTTNews
06:47AM EST  Pfizer And BioNTech Sign New Global Collaboration Agreement To Develop mRNA-based Shingles Vaccine; BioNTech to Receive $225M Upfront, Pfizer To Receive $25M For Proprietary Antigen Sequences Identified By Pfizer   Benzinga
06:45AM EST  Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine   Business Wire
06:45AM EST  Pfizer and BioNTech Sign New Global Collaboration Agreement to   GlobeNewswire Inc
Jan 4, 2022
09:42AM EST  UPDATE: CDC Says Booster Interval Recommendation For People Who Receive J&J Vaccine (2 Months) Or Moderna Vaccine (6 Months) Has Not Changed   Benzinga
09:37AM EST  CDC Recommends Pfizer Booster At 5 Months, Additional Primary Dose For Certain Immunocompromised Children   Benzinga
Jan 3, 2022
01:19PM EST  CDC to Hold Advisory Meeting on January 5 to Discuss Pfizer Covid-19 Vaccine Booster for 12-15 Year Olds   Benzinga
10:24AM EST  Starbucks To Require U.S. Vaccination Disclosure By Jan. 10; Unvaccinated Workers Will Need Weekly COVID Tests   Benzinga
10:07AM EST  U.S. Food and Drug Administration has expanded the emergency use authorization of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 12 years of age and older. The booster dose is the same dosage strength (30-microgram) as the dose approved in the primary series, the companies said in a statement.   RTTNews
09:56AM EST  'FDA...shortens time between Pfizer 2nd dose and booster to at least 5 months...' -Tweet From CNBC Pharma Reporter Meg Tirrell   Benzinga
09:53AM EST  Pfizer , BioNTech Receive U.S. FDA Emergency Use Authorization Of COVID-19 Vaccine Booster For 12 Years Of Age And Older   RTTNews
09:45AM EST  Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older   Business Wire
09:37AM EST  FDA Authorizes Pfizer Booster For People 12-15 Years Old   Benzinga
07:23AM EST  Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters   Benzinga
Dec 30, 2021
03:32PM EST  'Province set to announce fourth dose of COVID-19 vaccine for nursing home residents' -Toronto Star Report   Benzinga
01:58PM EST  Pfizer COVID Vaccine Safe For Children Aged 5 To 11   Benzinga
11:47AM EST  'F.D.A. Is Said to Be Near Allowing Boosters for 12- to 15-Year-Olds' -New York Times Report   Benzinga
Dec 29, 2021
08:01AM EST  FDA Is Looking At Boosters For Kids 12-15   Benzinga
Dec 27, 2021
04:06PM EST  Goldman Sachs Spokesperson Says Starting In Feb, Anyone Eligible To Get Booster Shot Will Be Required To Have One To Enter Goldman Offices In US   Benzinga
03:36PM EST  BioNTech Whale Trades For December 27   Benzinga
10:20AM EST  Israel Shortens Time Between Administering 2nd And 3rd COVID-19 Vaccine Doses To 3 Months From 5 Months, Health Ministry Says   Benzinga
06:45AM EST  MAINZ, Germany, December 27, 2021 BioNTech SE (Nasdaq: BNTX, BioNTech or the Company) announced today that CEO and Co-founder Ugur Sahin, M.D., will present a corporate overview and update at the virtual 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 9:45 am ET.   GlobeNewswire Inc
Dec 23, 2021
12:20PM EST  Oxford Lab Study Suggests AstraZeneca's COVID-19 Booster Works Against Omicron   Benzinga
12:13PM EST  UK Says COVID Omicron Variant Hospital Risk 50-70% Lower Than Compared To Delta Variant   Benzinga
11:18AM EST  'New Jersey reports more than 15,000 new COVID cases, more than double the pre-omicron record and up almost 60% in just one day' -Tweet From NBC New York   Benzinga
10:05AM EST  Pfizer, BioNTech, Moderna Shares Quiet Following Updated Data On COVID Vaccine For Ages 12-15 From Pfizer, BioNTech   Benzinga
10:04AM EST  UPDATE: Pfizer, BioNTech Say 2-Dose Series Of COVID Vaccine In Ages 12-15 Showed 100% Effective 4 Months After Second Dose   Benzinga
10:03AM EST  Pfizer, BioNTech Report Submission Of Updated Longer-Term Follow-Up Data On COVID Vaccine In Ages 12-15 Years To European Medicines Agency   Benzinga
05:56AM EST  U.S. Equity Futures Higher Ahead of Christmas Weekend; Positive News on Effectiveness of Vaccines Against Omicron Variant   Benzinga
Dec 22, 2021
03:54PM EST  'New York reports 28,924 new coronavirus cases, the biggest one-day increase on record, of which 17,221 are in New York City' -Tweet From BNO Newsroom   Benzinga
03:35PM EST  White House Advisor Dr. Fauci Says Attending Large Gatherings Of 40+ People Is Not Considered Safe For Vaccinated, Boosted People   Benzinga
01:34PM EST  Looking At BioNTech's Recent Whale Trades   Benzinga
11:22AM EST  Study Out Of Scotland Shows Risk Of Hospital Admission For Patients With COVID Omicron Variant Reduced By 2/3 vs Delta Variant   Benzinga
09:40AM EST  UK Regulator Has Approved Use Of Pfizer/BioNTech Vaccine In 5-10 Year Olds   Benzinga
05:38AM EST  U.S. Equity Futures Lower, European Markets Mixed; Governments Across the World Tighten Restrictions Due to Omicron Surge; Tech Companies Cancel Out of CES Vegas Event   Benzinga
Dec 21, 2021
03:36PM EST  'Majority in the Immunization Committee in Israel votes for the provision of a fourth vaccine dose to at-risk groups - vaccine-suppressed, adults over the age of 60 and health care workers.' -Israel Reporter Tweet   Benzinga
03:33PM EST  Reporter Amichai Stein Tweets: Majority in the Immunization Committee in Israel votes for the provision of a fourth vaccine dose to at-risk groups - vaccine-suppressed, adults over the age of 60 and health care workers   Benzinga
03:23PM EST  'Chicago to require proof of vaccination at restaurant, bars' -CNBC   Benzinga
10:40AM EST  Where BioNTech Stands With Analysts   Benzinga
10:34AM EST  Expert Ratings For BioNTech   Benzinga
10:24AM EST  NYC Mayor's Office Tweets '@NYCMayor just announced a new $100 incentive for New Yorkers if they get their booster shot at City-run sites before December 31.'   Benzinga
07:55AM EST  Germany's Stiko Vaccine Authority Recommends Boosters With mRNA Vaccines for Over 18s Three Months After Second Shot.   Benzinga
06:13AM EST  HC Wainwright & Co. Maintains Buy on BioNTech, Raises Price Target to $366   Benzinga
Dec 20, 2021
02:43PM EST  Biden Admin. Has Pushed Bank Enforcement Of New Vaccine Rules   Benzinga
11:34AM EST  WHO's Chief Scientist Says 'Very Dangerous' To Jump To Conclusion That All Vaccines, Except mRNA Shots, Are Not Working Against Omicron Variant   Benzinga
10:14AM EST  BioNTech shares were trading higher amid increasing COVID-19 cases.   Benzinga
10:05AM EST  Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY(r) to Help Meet Continued Need for Vaccine Supply   Business Wire
08:41AM EST  EMA Head Says COVID Vaccines Clearly Less Effective Against Omicron; Says Data On Omicron Not At All Definitive But It's Clear That There Is A Drop In Vaccine Effectiveness   Benzinga
07:36AM EST  Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Monday an agreement has been reached with the European Commission (EC) and its member states to exercise an option to purchase more than 200 million additional doses of COMIRNATY, the companies' COVID-19 vaccine. Contractual details are currently being finalized.   RTTNews
07:23AM EST  Pfizer And BioNTech To Provide More Than 200 Mln Addl Doses Of COMIRNATY To EU In 2022   RTTNews
05:28AM EST  U.S. Equity Futures, European Markets Fall Sharply Over Rising Omicron Concerns; Two U.S. Senators Test Positive for Covid-19; Moderna Said Booster Effective vs Omicron; Senator Manchin Says he Will Not Support Biden Spending Bill   Benzinga
Dec 19, 2021
07:20PM EST  New Jersey Democratic Senator Cory Booker Says He Has Tested Positive for Covid-19   Benzinga
05:16PM EST  Massachusetts Senator Warren Tests Positive for Covid-19   Benzinga
Dec 17, 2021
10:32AM EST  Pfizer Says Is Currently Assuming COVID Will Transition To An Endemic Phase In 2024 Time Frame   Benzinga
09:34AM EST  'Pfizer saying that it plans to update its vaccine to be a three-dose vaccine, rather than two doses.' -Recent Tweet From POLITICO FDA Reporter   Benzinga
09:34AM EST  'Pfizer saying that it plans to update its vaccine to be a three-dose vaccine, rather than two doses.' -Tweet From POLITICO FDA Reporter   Benzinga
09:25AM EST  Pfizer Expects COVID-19 Vaccine Sales Of Approximately $31B In 2022   Benzinga
08:10AM EST  White House Says No New Recommendations Yet On COVID-19 Amid Omicron But Continuing To Assess Any Possible New Steps   Benzinga
07:54AM EST  The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx   Benzinga
05:32AM EST  Head of the European Commission Said European Union Governments Agreed to Order 180M+ Doses of Version Tailored to Protect Against Omicron Varian   Benzinga
Dec 16, 2021
05:04PM EST  Pfizer, BioNTech Submit Supplemental Biologics License Application For FDA Approval Of Comirnaty In Adolescents 12-15 Years Of Age   Benzinga
03:45PM EST  'CDC advisory committee vote on whether to say mRNA #covid19 vaccines are preferred over J&J vaccine for everyone 18+: Yes: 15 No: 0' -Tweet From CNBC's Meg Tirrell   Benzinga
01:45PM EST  'De Blasio says NYC looking at question of requiring boosters for teachers and other city employees "on the front burner," will say more soon' -NBC New York Report   Benzinga
12:16PM EST  CDC Says There Have Been 8 Reports To Vaccine Adverse Event Reporting System That Meet Definition Of Myocarditis Among Children Aged 5-11 Who Received COVID-19 Vaccine   Benzinga
12:15PM EST  U.S. CDC Says No Confirmed Reports Of Myocarditis In Vaccine Safety Datalink Monitoring System Among Children Aged 5-11 Who Received COVID-19 Vaccine   Benzinga
10:14AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021   Benzinga
09:41AM EST  Analyst Ratings For BioNTech   Benzinga
05:58AM EST  Morgan Stanley Initiates Coverage On BioNTech with Equal-Weight Rating, Announces Price Target of $294   Benzinga
Dec 15, 2021
11:34AM EST  'Our booster vaccine regimens work against omicron - at this time there's no need for a variant-specific booster," Dr Fauci says at @WHCOVIDResponse briefing' -Tweet From CNBC's Meg Tirrell   Benzinga
11:27AM EST  CDC's Walensky Says Will Release Vaccine, Booster Data On Thursday   Benzinga
11:27AM EST  CDC's Walensky Says Early Data Suggests Omicron Has A Doubling Time Of About 2 Days According To Early Research   Benzinga
11:15AM EST  European Medicines Committee Backs Johnson & Johnson's COVID-19 Booster Dose   Benzinga
11:13AM EST  Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back   Benzinga
Dec 14, 2021
03:33PM EST  Cornell Imposes Lockdown After Omicron Is Detected On Campus   Benzinga
03:31PM EST  CORRECTION: BioNTech Is A Partner With Pfizer On COVID-19 Vaccine, Not Antiviral Treatments   Benzinga
03:29PM EST  President Biden Says He Is Encouraged By Data Released By Pfizer Today, Showing That Its Antiviral Pill Is Effective At Reducing Risk Of Severe Illness   Benzinga
12:43PM EST  South African Study Shows Omicron Variant Could Escape Pfizer/BioNTech COVID-19 Vaccine Protection   Benzinga
11:27AM EST  World Health Organization Chief Tedros Says People Are Wrong To Consider Omicron Variant As Causing Mild Disease, That Sentiment Could Overwhelm Unprepared Health Systems   Benzinga
10:16AM EST  NFL Mandates Booster Shots Among Team Staff   Benzinga
Dec 13, 2021
02:20PM EST  This Is What Whales Are Betting On BioNTech   Benzinga
11:24AM EST  UK Reports First Omicron Death, PM Johnson Encourages Boosters   Benzinga
05:12AM EST  University of Oxford Study Shows Two-dose Covid-19 Vaccine Regimens Do Not Induce Enough Neutralizing Antibodies vs Omicron Coronavirus Variant   Benzinga
Dec 12, 2021
10:57AM EST  Israeli Study Says Pfizer Booster Shots Are Effective Against Omicron Variant; Said Users Unlikely to Develop Severe Illness or be Hospitalized   Benzinga
Dec 10, 2021
01:58PM EST  This Is What Whales Are Betting On BioNTech   Benzinga
01:31PM EST  Check Out What Whales Are Doing With BNTX   Benzinga
01:29PM EST  BioNTech Whale Trades Spotted   Benzinga
12:34PM EST  Switzerland Approves Pfizer-BioNTech Vaccine For Ages 5-11   Benzinga
11:43AM EST  UK Health Security Agency Says Booster Increases Protection Against Mild COVID Disease To Around 70%-75% In Real World Study Looking At 581 People With Confirmed Omicron Variant   Benzinga
Dec 9, 2021
09:56PM EST  'Gov. Kathy Hochul said she will announce new policies tomorrow as more cases of the Omicron variant are confirmed in New York.' -CBS New York   Benzinga
09:53PM EST  Pfizer, BioNTech Receive U.S. FDA Emergency Use Authorization Of COVID-19 Vaccine Booster For Individuals 16 Years And Older   Benzinga
09:52PM EST  UPDATE: Older Teens Can Get Pfizer-BioNTech Booster Six Months After First Two Doses   Benzinga
09:52PM EST  Pfizer-BioNTech COVID-19 Booster Authorized For 16- And 17-Year-Olds   Benzinga
09:43PM EST  Alibaba, JD, Baidu And Nio Rival Li Auto Lead Hang Seng Higher On China Policy Easing Optimism   Benzinga
09:42PM EST  Crypto Daily: Is V-Shaped Recovery In The Cards For Bitcoin, Why Ethereum Is Rising Amid Bearish Sentiments And More   Benzinga
09:42PM EST  'Senate votes to repeal key Biden administration vaccine and testing policy' -Earlier Washington Post Report   Benzinga
12:58PM EST  Drug major Pfizer Inc (PFE) and German partner BioNTech SE (BNTX) Thursday announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization of a booster dose of its COVID-19 Vaccine to include 16 and 17-year olds.   RTTNews
12:15PM EST  -- First emergency use authorization in the United States for a COVID-19 vaccine booster in individuals 16 years and older   GlobeNewswire Inc
12:14PM EST  Pfizer And BioNTech Receive FDA Emergency Use Authorization Of COVID-19 Vaccine Booster For 16 Years And Older   RTTNews
12:07PM EST  Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older   Business Wire
08:41AM EST  Direxion Launches mRNA ETF (MSGR)   PR Newswire
Dec 8, 2021
12:08PM EST  Pfizer CEO Says Will Maintain 4B Shot Capacity With Omicron Variant Doses   Benzinga
12:07PM EST  CORRECTION: Pfizer CEO Says 3rd Vaccine Shot Will Do Job Vs Omicron Variant   Benzinga
12:07PM EST  Pfizer CEO Says 3rd Vaccine Shot Will Do Job Vs Omicron Variant   Benzinga
12:07PM EST  Pfizer CEO Says Expect Real-World Effectiveness Data By Year End   Benzinga
12:04PM EST  BioNTech CEO Says 3rd Vaccine Shot Will Do Job Vs Omicron Variant   Benzinga
09:54AM EST  BioNTech shares were trading higher after the company, along with Pfizer, announced a third vaccine dose neutralizes the Omicron variant while two doses show significantly reduced neutralization titers.   Benzinga
09:54AM EST  BioNTech CEO Says An Omicron-Adapted Booster Will Not Immediately Be Broadly Available Even If Supply Starts In March; Will Start As First 25M To 75M Doses   Benzinga
09:45AM EST  BioNTech CEO Says Data On 12-15 Year Olds Vs Omicron Variant Will Be Available Sometime Next Week; Says Need More Data To Know If Children Will Need 3rd Dose   Benzinga
09:30AM EST  BioNTech CEO Says Upcoming Further Data On Vaccine Effectiveness vs Omicron Variant Will Likely Result In Talks To Move Booster Shots Closer To Dose 2   Benzinga
09:30AM EST  BioNTech CEO Says Co. Will Have [More] Data On Effectiveness Of Its COVID Vaccine Against Omicron Variant In 6-8 Weeks   Benzinga
09:18AM EST  Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Dec. 8, 2021: BNTX, ROKU, PHUN, RKLB, NU   Benzinga
07:20AM EST  Pfizer Inc. (PFE) and BioNTech SE (BNTX) reported results from an initial laboratory study showing that serum antibodies induced by the Pfizer-BioNTech COVID-19 vaccine neutralized the SARS-CoV-2 Omicron variant after three doses.   RTTNews
07:15AM EST  BioNTech to Hold Digital Press Conference to Provide an Update on   GlobeNewswire Inc
06:58AM EST  Pfizer/BioNTech PR Highlights Studies On Three Doses Of Pfizer-BioNTech COVID-19 Vaccine In Omicron; Says 'Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant'   Benzinga
06:58AM EST  Pfizer : Initial Study Shows Serum Antibodies Induced By Pfizer-BioNTech COVID-19 Vaccine Neutralize Omicron Variant   RTTNews
06:57AM EST  Pfizer and BioNTech Provide Update on Omicron Variant   GlobeNewswire Inc
06:49AM EST  S&P Futures Spike Higher on News of Three Doses of Pfizer-Biontech Vaccine Effective vs Omicron   Benzinga
06:47AM EST  Pfizer and BioNTech Say Three Vaccine Doses Neutralize Omicron Variant; Two Dose Vaccine Significantly Less Effective vs Omicron But May Still Prevent Sever Disease   Benzinga
Dec 7, 2021
05:18PM EST  Watching BioNTech, Pfizer Shares Following Tweet From CNBC Pharma Reporter Meg Tirrell 'BioNTech CEO Ugur Sahin tells NBC News' @AkshaySyal they expect their own data on vaccine vs omicron tomorrow or Thursday. "I would be more optimistic," he said.'   Benzinga
03:28PM EST  UPDATE: South African Study Shows Pfizer Vaccine Less Effective Against Omicron Variant Than vs Beta Variant   Benzinga
01:03PM EST  Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response   Benzinga
10:01AM EST  Pfizer To Host Webcast For Investment Analysts Dec. 17 At 8:30 a.m. EST To Discuss Co., BioNTech's COVID-19 Vaccine, Co.'s Oral Antiviral Treatment Candidate   Benzinga
Dec 6, 2021
01:50PM EST  CNN Reporter Tweets 'Good news on Omicron and vaccines: "The early indication is that you are going to be protected against serious illness with two doses of mRNA-containing vaccines. And the booster dose can increase antibodies,"'   Benzinga
10:27AM EST  UPDATE: Children Aged 5-11 Required To have At Least 1 COVID Vaccine Shot For Indoor Activities Starting Dec. 14   Benzinga
10:07AM EST  BioNTech SE (BNTX) shares are declining on Monday morning trade, continuing a slide since November 26. There have been no company-specific news today that could hurt the stock.   RTTNews
06:07AM EST  The Week Ahead In Biotech (Dec. 6-Dec. 11): Dar FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More   Benzinga
05:23AM EST  Pfizer/BioNTech's COVID-19 Shot Receives Emergency Use Nod In Australia For Kids Aged 5-11 Years   Benzinga
Dec 5, 2021
09:15AM EST  CDC Director Walensky Said Omicron Covid-19 Cases Found in at Least 15 U.S. States; Said Delta Variant of Covid-19 Still Makes Up Majority of U.S. Cases   Benzinga
Dec 3, 2021
03:40PM EST  Pfizer, BioNTech Shares Quiet Following Comment From Biden Chief Medical Advisor Dr. Fauci Says Pfizer's COVID-19 Vaccine Likely To Retain Effect Against Omicron Strain   Benzinga
05:38AM EST  Biontech CEO Said New Variant Might Be Able to Infect Vaccinated People and People With High Exposure to Covid-19; Said It's Not Clear if Vaccinated People Have Sufficient Protection to Avoid Severe Disease from New Variant, We Anticipate Vaccinated People Will Be Protected From Severe Disease   Benzinga
Dec 2, 2021
04:17PM EST  NYC Sets Vaccine Mandate For Religious, Private School Staff   Benzinga
01:53PM EST  President Biden Says Team Is Working With Vaccine Firms For Contingency Plan For Vaccines, Boosters   Benzinga
12:54PM EST  Europe To Start Deliveries Of Pfizer/BioNTech COVID-19 Shot For Children One Week Ahead Of Plan: Reuters   Benzinga
07:51AM EST  The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance   Benzinga
Dec 1, 2021
12:03PM EST  Former German PM Merkel Proposes Mandatory COVID Shots Starting Feb. 2022   Benzinga
07:18AM EST  WHO Official Says Some of the Early Indications Is That Most Omicron Cases Are Mild, No Severe Cases   Benzinga
06:36AM EST  Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition   Benzinga
05:45AM EST  Norway Detected First Two Cases of Omicron Covid Variant   Benzinga
05:11AM EST  Japan Confirmed Second Case of Omicron Variant of the Covid-19 on Wednesday   Benzinga
05:00AM EST  Israel's Health Minister Nitzan Horowitz Said Individuals Fully Vaccinated Against Corona Within Six Months or With the Booster are Protected Against the Omicron Variant   Benzinga
04:54AM EST  EU Launch of Pfizer/BioNTech COVID for Children Aged 5-11 Brought Forward by a Week to December 13   Benzinga
Nov 30, 2021
04:53PM EST  'Omicron Unlikely to Cause Severe Illness in Vaccinated People, BioNTech Founder Says' -Wall Street Journal Report   Benzinga
04:49PM EST  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Nov. 30, 2021: TWTR, BNTX, COST, MRVL, ADGI   Benzinga
04:42PM EST  Two Israeli Doctors Infected with Omicron Variant   Benzinga
04:42PM EST  FDA May Authorize Pfizer-BioNTech COVID-19 Booster Shots For Age 16-17 Next Week: WSJ   Benzinga
04:40PM EST  China Xinhua News Says No Omicron Cases Reported on Chinese Mainland So Far   Benzinga
04:39PM EST  U.S. Equity Futures, European Markets Fall Following Moderna CEO Comments on Vaccines Likely Less Effectiveness Against Omicron Variant   Benzinga
04:39PM EST  Dutch Authorities Said Omicron Variant Was Detected in the Netherlands on Nov. 19, Before S. Africa Flights   Benzinga
04:39PM EST  Moderna CEO Said in Financial Times Interview Vaccines are Likely Less Effective against Omicron; Said Mutations Mean Existing Vaccines Likely Need Modifying   Benzinga
04:23PM EST  Merriam-Webster Names 'Vaccine' As 2021 Word Of The Year   Benzinga
04:17PM EST  White House Says Nothing Has Changed In Our Deadline For Required Vaccinations Of Federal Workers   Benzinga
04:11PM EST  President Biden Says Medical Team Believes Vaccines Provide Protection; Says Team Is Working With Moderna, Pfizer On Contingency Plan   Benzinga
10:16AM EST  Shares of German biotechnology company BioNTech SE (BNTX) are moving down 6 percent on Tuesday's trading even while there is renewed focus on vaccine makers with the discovery of the omicron variant of the coronavirus.   RTTNews
07:03AM EST  Drug major Pfizer Inc (PFE) and German partner BioNTech SE (BNTX) are likely to seek approval from the U.S. Food and Drug Administration for their COVID-19 vaccine booster shot for 16 and 17-year olds, the Washington Post reported citing people familiar with the matter.   RTTNews
Nov 29, 2021
09:06PM EST  The U.S. Centers for Disease Control and Prevention has strengthened its recommendation for COVID-19 booster shots for all U.S. adults amid growing concern about the new omicron variant. The agency previously said all adults may get the booster shot.   RTTNews
08:36AM EST  Major covid vaccine makers said they are investigating Omicron, the new, heavily mutated coronavirus variant that was first detected in South Africa, and working to adapt their vaccines, if needed.   RTTNews
08:25AM EST  Pfizer CEO Says If There Is A Need For A New Vaccine We'll Make Almost 4B Doses Of New Vaccine Next Year   Benzinga
08:21AM EST  Pfizer CEO Says Might Need Annual Vaccinations To Fight COVID-19   Benzinga
08:11AM EST  Pfizer CEO Says Friday We Made A New Templated On Developing A New Vaccine For Omicron Variant   Benzinga
08:10AM EST  Pfizer CEO Says Our Treatment Was Designed With Mutations In Mind; Says Will Understand Omicron More 'Within Weeks'   Benzinga
06:29AM EST  'Technical paper on the #COVID19 variant of concern, Omicron. It includes a set of preparedness actions for countries' - World Health Organization   Benzinga
06:26AM EST  World Health Organization Tweeted Earlier "We don't yet know whether Omicron is associated with more: -transmission -severe #COVID19 disease -risk of reinfections -risk of evading vaccines. Scientists at WHO & around the   Benzinga
05:58AM EST  Italy's Radiocor Says Italy Reported Four Omicron Variant Cases   Benzinga
Nov 28, 2021
05:07PM EST  NIH Director Collins Said Current Vaccinations Likely to Protect Against Omicron   Benzinga
09:14AM EST  National Institute of Allergy and Infectious Diseases Director Fauci Tells ABC News Too Early to Say if We Need New Lockdowns or Mandates   Benzinga
Nov 27, 2021
09:23AM EST  Two cases of Omicron Variant Detected in UK: Individuals in Chelmsford and Nottingham had Traveled to Southern Africa   Benzinga
Nov 26, 2021
11:47AM EST  Mid-Day Market Update: Dow Tumbles Over 900 Points; Crude Oil Down 12%   Benzinga
11:45AM EST  A Look Into BioNTech's Price Over Earnings   Benzinga
10:13AM EST  Mid-Morning Market Update: Markets Open Lower; Europe's Regulator Backs Pfizer's COVID-19 Vaccine For Kids Aged 5-11 Years   Benzinga
08:20AM EST  Pfizer Says If Vaccine-Escape Variant Emerges, Cos Expect To Develop, Produce Tailor-Made Vaccine Against That Variant In About 100 Days   Benzinga
08:13AM EST  Denmark To Recommend Vaccinating Children Aged 5-11 With Pfizer-BioNTech COVID-19 Vaccine If EU Approves Usage   Benzinga
07:07AM EST  BioNTech Expects Data From Lab Tests On New Variant In 2 Weeks; Says Depending On Lab Data May Require Vaccine Adjustment   Benzinga
06:15AM EST  Top 10 WallStreetBets Stocks In Premarket Session for Nov. 26, 2021: PTON, GME, TDOC, TSLA, AMD, DIS, NVDA, OPEN, BNTX, AMC   Benzinga
05:43AM EST  France, Czech Republic, Singapore Among Countries Reported to Restrict Travel from Southern Africa Due to "Nu" Variant   Benzinga
05:15AM EST  Total of 84 Confirmed Cases of COVID-19 Variant B.1.1.529 With 77 in S. Africa, 4 in Botswana, 2 in Hong Kong, 1 in Israel   Benzinga
05:12AM EST  U.S. Equity Futures Sharply Lower; Covid-Related Stocks Surge on Reports of New, Heavily-Mutated Strain, Feared to be More Infectious than Delta Variant   Benzinga
05:09AM EST  Israeli, Who Returned from Malawi, Tested Positive for New Highly-Mutated Covid-19 Strain Reported in S. Africa   Benzinga
Nov 25, 2021
09:39AM EST  Pfizer, BioNTech Get Positive CHMP Opinion For COMIRNATY For Kids Aged 5-11 In The European Union   RTTNews
07:30AM EST  Pfizer and BioNTech Receive Positive CHMP Opinion for   GlobeNewswire Inc
Nov 24, 2021
02:00PM EST  Johnson & Johnson's COVID-19 Shot Wins Its First Full Approval In Canada   Benzinga
06:44AM EST  World Health Organization Issues Interim Statement on Covid-19 Vaccination for Children and Adolescents, Says They Have Lower Risk of Severe Disease   Benzinga
06:04AM EST  South Africa Asked Johnson & Johnson and Pfizer to Delay Delivery of COVID-19 Vaccines Due to Oversupply   Benzinga
Nov 23, 2021
05:08PM EST  Fauci Says Cast Majority Of Vaccinated Americans Should Get COVID-19 Boosters; Says Has Seen No Safety Signal Related To COVID-19 Vaccine Campaign For Children   Benzinga
02:16PM EST  Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst   Benzinga
07:17AM EST  Novartis May Have Buyer(s) For Its Sandoz Unit - Report   Benzinga
Nov 22, 2021
12:41PM EST  EU Says Decision On J&J COVID-19 Booster Shot Expected 'Within Weeks'   Benzinga
07:11AM EST  Pfizer Inc. (PFE) and BioNTech SE (BNTX) said that updated findings from pivotal phase 3 trial of their COVID-19 vaccine supported safety and high efficacy in Adolescents 12 through 15 years of age.   RTTNews
06:49AM EST  Pfizer : Follow-Up Data From Phase 3 Trial Of COVID-19 Vaccine Support Safety And High Efficacy In Adolescents   RTTNews
06:48AM EST  Follow-Up Data From Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety And High Efficacy In Adolescents 12 Through 15 Years Of Age   Benzinga
06:47AM EST  Follow-Up Data From Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Demonstrated 100% Efficacy Against COVID-19 In Longer-term Analysis, With No Serious Safety Concerns Identified   Benzinga
06:45AM EST  Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age   Business Wire
06:45AM EST  -- Pfizer-BioNTech vaccine demonstrated 100% efficacy against COVID-19 in longer-term analysis, with no serious safety concerns identified -- Data will support planned submissions for full regulatory approval of the vaccine in this age group in the U.S. and worldwide   GlobeNewswire Inc
Nov 19, 2021
03:21PM EST  CDC Advisers Vote To Recommend That People Aged 50 And Above Should Get COVID -19 Vaccine Booster Doses   Benzinga
12:16PM EST  CDC Safety Group Says Myocarditis Risk After Pfizer Booster Shot Appears Lower Than After Second Dose   Benzinga
09:00AM EST  FDA Grants Expanded EUA To Pfizer, BioNTech COVID-19   RTTNews
08:29AM EST  Pfizer , BioNTech Receive Expanded FDA Emergency Nod Of COVID-19 Vaccine Booster To Include 18 Yrs And Older   RTTNews
08:25AM EST  -- Expanded authorization allows more Americans to receive a booster dose to help preserve a high-level of protection against COVID-19   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC